A study to investigate safety, tolerability and clinical response with SAR441566 compared with placebo in participants with mild to moderate psoriasis

Trial Identifier: PDY16918
Sponsor: Sanofi
Start Date: July 2022
Primary Completion Date: February 2023
Study Completion Date: February 2023
Condition: Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Germany Berlin, Germany, 10117